Adeel Ilyas1,2, Ching-Jen Chen2, Dale Ding2,3, Thomas J Buell2, Daniel M S Raper2, Cheng-Chia Lee4, Zhiyuan Xu2, Jason P Sheehan2. 1. Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama. 2. Department of Neurological Surgery, University of Virginia Health System, Charlottesville, Virginia. 3. Department of Neurosurgery, Barrow Neurologic Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona. 4. Department of Neurological Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
Abstract
BACKGROUND: Radiation-induced changes (RICs) are the most common complication of stereotactic radiosurgery (SRS) for brain arteriovenous malformations (AVMs), and they appear as perinidal T2-weighted hyperintensities on magnetic resonance imaging, with or without associated neurological symptoms. OBJECTIVE: To determine the rates of RIC after AVM SRS and identify risk factors. METHODS: A literature review was performed using PubMed and MEDLINE to identify studies reporting RIC in AVM patients treated with SRS. RICs were classified as radiologic (any neuroimaging evidence), symptomatic (any associated neurological deterioration, regardless of duration), and permanent (neurological decline without recovery). Baseline, treatment, and outcomes data were extracted for statistical analysis. RESULTS: Based on pooled data from 51 studies, the overall rates of radiologic, symptomatic, and permanent RIC after AVM SRS were 35.5% (1143/3222 patients, 32 studies), 9.2% (499/5447 patients, 46 studies), and 3.8% (202/5272 patients, 39 studies), respectively. Radiologic RIC was significantly associated with lack of prior AVM rupture (odds ratio [OR] = 0.57; 95% confidence interval [CI]: 0.47-0.69; P < .001) and treatment with repeat SRS (OR = 6.19; 95% CI: 2.42-15.85; P < .001). Symptomatic RIC was significantly associated with deep AVM location (OR = 0.38; 95% CI: 0.21-0.67; P < .001). CONCLUSION: Approximately 1 in 3 patients with AVMs treated with SRS develop radiologically evident RIC, and of those with radiologic RIC, 1 in 4 develop neurological symptoms. Lack of prior AVM hemorrhage and repeat SRS are risk factors for radiologic RIC, and deep nidus location is a risk factor for symptomatic RIC.
BACKGROUND: Radiation-induced changes (RICs) are the most common complication of stereotactic radiosurgery (SRS) for brain arteriovenous malformations (AVMs), and they appear as perinidal T2-weighted hyperintensities on magnetic resonance imaging, with or without associated neurological symptoms. OBJECTIVE: To determine the rates of RIC after AVM SRS and identify risk factors. METHODS: A literature review was performed using PubMed and MEDLINE to identify studies reporting RIC in AVM patients treated with SRS. RICs were classified as radiologic (any neuroimaging evidence), symptomatic (any associated neurological deterioration, regardless of duration), and permanent (neurological decline without recovery). Baseline, treatment, and outcomes data were extracted for statistical analysis. RESULTS: Based on pooled data from 51 studies, the overall rates of radiologic, symptomatic, and permanent RIC after AVM SRS were 35.5% (1143/3222 patients, 32 studies), 9.2% (499/5447 patients, 46 studies), and 3.8% (202/5272 patients, 39 studies), respectively. Radiologic RIC was significantly associated with lack of prior AVM rupture (odds ratio [OR] = 0.57; 95% confidence interval [CI]: 0.47-0.69; P < .001) and treatment with repeat SRS (OR = 6.19; 95% CI: 2.42-15.85; P < .001). Symptomatic RIC was significantly associated with deep AVM location (OR = 0.38; 95% CI: 0.21-0.67; P < .001). CONCLUSION: Approximately 1 in 3 patients with AVMs treated with SRS develop radiologically evident RIC, and of those with radiologic RIC, 1 in 4 develop neurological symptoms. Lack of prior AVM hemorrhage and repeat SRS are risk factors for radiologic RIC, and deep nidus location is a risk factor for symptomatic RIC.
Authors: Ethan M Glazener; Kenneth Lodin; Michael J Miller; Matthew J Frager; Javad Rahimian; Joseph C T Chen; Michael R Girvigian Journal: Adv Radiat Oncol Date: 2020-04-13
Authors: Maria Correia de Verdier; Elisabeth Ronne-Engström; Ljubisa Borota; Kristina Nilsson; Erik Blomquist; Johan Wikström Journal: Acta Radiol Open Date: 2021-11-01
Authors: B J Daou; G Palmateer; D A Wilkinson; B G Thompson; C O Maher; N Chaudhary; J J Gemmete; J A Hayman; K Lam; D R Wahl; M Kim; A S Pandey Journal: AJNR Am J Neuroradiol Date: 2020-11-19 Impact factor: 3.825
Authors: Myung Ji Kim; Kyung Won Chang; So Hee Park; Won Seok Chang; Jong Hee Chang; Jin Woo Chang; Hyun Ho Jung Journal: J Clin Med Date: 2021-05-19 Impact factor: 4.241
Authors: Michael T Milano; Jimm Grimm; Andrzej Niemierko; Scott G Soltys; Vitali Moiseenko; Kristin J Redmond; Ellen Yorke; Arjun Sahgal; Jinyu Xue; Anand Mahadevan; Alexander Muacevic; Lawrence B Marks; Lawrence R Kleinberg Journal: Int J Radiat Oncol Biol Phys Date: 2020-09-11 Impact factor: 8.013